risperidone has been researched along with Chronic Pain in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic pain is considered one of the most prevalent causes of costly and disabling medical conditions." | 2.53 | Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics. ( Khouzam, HR, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoshima, M | 1 |
| Suzuki, Y | 1 |
| Masuda, Y | 1 |
| Yoshinari, Y | 1 |
| Hashizume, H | 1 |
| Tokura, Y | 1 |
| Khouzam, HR | 1 |
1 review available for risperidone and Chronic Pain
| Article | Year |
|---|---|
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodi | 2016 |
1 other study available for risperidone and Chronic Pain
| Article | Year |
|---|---|
Successful treatment of chronic intractable pain with risperidone in a patient with acquired idiopathic generalized anhidrosis.
Topics: Biopsy; Chronic Pain; Humans; Hypohidrosis; Male; Middle Aged; Pain, Intractable; Risperidone; Serot | 2018 |